Macleods Pharmaceuticals Ltd is a prominent global pharmaceutical company established in 1989, headquartered in Mumbai, India. The company is engaged in the development, manufacturing, and marketing of a diverse range of pharmaceutical formulations across various therapeutic areas.
Checking authentication...
Checking authentication...
In a significant boost to the Indian economy, Macleods Pharmaceuticals, TBO Tek, and Suraj Estate Developers have received the green light from SEBI for their IPOs. This development signals positive growth and increased investor confidence in the Indian market, paving the way for substantial capital infusion.
Macleods Pharmaceuticals, a major player in the pharma sector, is preparing to launch its IPO, potentially the largest in the sector to date. The company has filed its draft papers with SEBI.
| P&L Statement | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 8217 | 8223 | 6451 | - |
| Cost of Material Consumed | TBD | - | - | - |
| Gross Margins | 0.61 | - | - | - |
| Change in Inventory | TBD | - | - | - |
| Employee Benefit Expenses | TBD | - | - | - |
| Other Expenses | TBD | - | - | - |
| EBITDA | 1758 | 1714 | 1540 | - |
| OPM | 0.22 | - | - | - |
| Other Income | - | - | - | - |
| Finance Cost | - | - | - | - |
| D&A | 170 | 170 | 170 | 170 |
| EBIT | 1588 | 1544 | 1370 | - |
| EBIT Margins | 0.19 | 0.19 | 0.21 | - |
| PBT | 1200 | 1200 | 1200 | - |
| PBT Margins | 0.15 | 0.15 | 0.19 | - |
| Tax (2021) | Approx. 30% of PBT | - | - | - |
| PAT | 1229 | 1666 | 1590 | - |
| NPM | 0.15 | - | - | - |
| EPS | - | - | - | - |
| Financial Ratios | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Operating Profit Margin | 0.334 | 0.209 | 0.186 | 22-23% |
| Net Profit Margin | 0.316 | 0.156 | 0.189 | ~15.6% |
| Earning Per Share (Diluted) | ₹37.0 | ₹19.5 | ₹24.6 | ~₹24.64 |
| Promoters | Designation | Experience | Linkedin Profile |
|---|---|---|---|
| Banwarilal Murlidhar Bawri | Director | 35+ | - |
| Girdharilal Murlidhar Bawri | Director | 14 | - |
| ajendra Murlidhar Agarwal | Director | 15 | - |
In a significant boost to the Indian economy, Macleods Pharmaceuticals, TBO Tek, and Suraj Estate Developers have received the green light from SEBI for their IPOs. This development signals positive growth and increased investor confidence in the Indian market, paving the way for substantial capital infusion.
Macleods Pharmaceuticals, a major player in the pharma sector, is preparing to launch its IPO, potentially the largest in the sector to date. The company has filed its draft papers with SEBI.
Access essential information and documents to make informed investment decisions
Stay updated with upcoming events, conferences, and announcements
Access quarterly and half-yearly financial statements and reports
Download comprehensive annual reports and financial summaries
Access investor presentations, corporate briefings, and slideshows
The current market price of Macleods Pharma unlisted shares is ₹505 per share.
The minimum lot size is - shares, and trades must be placed in multiples of this.
The shares have traded as high as ₹- and as low as ₹- over the past year.
The shares are held in - depositories under ISIN INE182R01013.
Macleods Pharma Shares's market capitalization is approximately 30240 crore.
The company has P/E ratio of ₹24.6, P/B ratio of 6.85, Debt-to-Equity ratio of 0.0184, ROE of 23.96%.
The book value of Macleods Pharma Shares is ₹73.72 per share.
The face value of Macleods Pharma unlisted shares is ₹100.0 per share.
Macleods Pharma Shares has 598820400 shares outstanding.
Our blog provides insightful information about unlisted shares, offering a deeper understanding of how these assets work, their potential benefits, and the risks involved. Whether you're new to unlisted shares or looking to expand your knowledge, we cover topics such as investment strategies, valuation methods, market trends, and regulatory aspects. Stay updated with expert tips and guides to navigate the unlisted share market effectively.
Discover a variety of unlisted shares beyond the popular picks. Stay updated with real-time pricing, emerging opportunities, and market trends to diversify your portfolio and make confident investment decisions.
₹1890
.avif&w=256&q=75)
₹455
₹900
₹28
₹106
₹135
